Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

$120 per share for NAVB? Let the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
casperboo Member Profile
 
Followed By 6
Posts 1,019
Boards Moderated 1
Alias Born 02/13/10
160x600 placeholder
Navidea Announces Scientific Presentations of Results from Lymphoseek® Studies at the European Association of Nuclear Medici... "Business Wire" - 10/30/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Third Quarter 2014 Financial Results on November 6, 2014 "Business Wire" - 10/29/2014 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/16/2014 5:25:31 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/15/2014 4:45:59 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 10/15/2014 4:03:40 PM
Navidea Announces Rick Gonzalez as New Chief Executive Officer "Business Wire" - 10/15/2014 8:00:00 AM
FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors "Business Wire" - 10/15/2014 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/8/2014 4:05:27 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/1/2014 1:05:05 PM
Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor Conference September 30th "Business Wire" - 9/29/2014 3:36:00 PM
Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast & Ce... "Business Wire" - 9/26/2014 7:27:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 4:40:16 PM
Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek® in Cervical Cancer "Business Wire" - 9/23/2014 7:30:00 AM
Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers "Business Wire" - 9/18/2014 4:07:00 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 9/16/2014 12:31:06 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 9/12/2014 4:11:24 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/10/2014 10:16:54 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/4/2014 5:54:05 PM
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China "Business Wire" - 9/4/2014 7:30:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/22/2014 7:06:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2014 4:07:13 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2014 3:54:17 PM
Navidea Announces Second Quarter 2014 Financial Results; Total Revenues Grow to $1.1 Million "Business Wire" - 8/6/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Second Quarter 2014 Financial Results on August 6, 2014 "Business Wire" - 7/29/2014 9:37:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2014 5:18:04 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist